Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshinori Katoh is active.

Publication


Featured researches published by Yoshinori Katoh.


Ensho | 1994

Comparison of the efficacy of indometacin farnesil and indometacin against various symptoms in adjuvant-induced knee-arthritis in dogs.

Yoshinori Katoh; Mamoru Tanaka; Akira Matsumoto; Sumiko Takahashi; Kenji Nakano; Tetsuya Nakamura

Using subacute arthritis induced by inoculation of Freunds complete adjuvant into the knee-joint of beagles, the anti-inflammatory effect of indometacin farnesil (IMF) was observed and compared with that of indometacin (IND) . The side effects of both drugs were studied as well. The therapeutic efficacy of the two drugs was clarified through comparison of the efficacy rates against arthritis and those for side effects.Freunds complete adjuvant was injected into the knee-joints of the beagles 5 min before the initial administration of the test drugs. Thereafter, the test drugs were administered at 2 dose levels egivalent to clinical rates, once a day for 8 days. Local inflammatory symptoms such as pain, hyperthermia and swelling in the inflammatory lesions were monitored and the rectal temperature was measured during the experiment. Three hours after the final administration, PGE2, IND and IMF concentrations in the synovial fluid, and PGE2⋅I2 and IND concentrations were measured in the pyloro-duodenum. The pyloroduodenum was also investi-gated histologically. Both IMF (30mg/kg) and IND (1.7mg/kg) reduced pain dose-dependently and were almost equipotent in analgesic activity on the 3rd day.Only IMF (30mg/kg) showed a significant ability to reduce the higher temperature in the inflamed joints (p<0.05) . IMF (30mg/kg) and IND (5.0mg/kg) were almost equipotent in anti-pyretic activity on both the 1st and 3rd days. A significant amount of IND, which might have come from the blood stream and/or result from the hydrolysis of IMF in the synovial fluid, and levels of PGE2 lower than those of the control detected in the synovial fluids in both the IMF and IND groups, seem to indicate that the anti-inflammatory and analgesic effects are due to the tissue levels of IND, which inhibited the action of cyclooxygenase in the fluid.The side effects in the IND groups were very severe with bloody stool in one out of six and four out of six animals in the 1.7mg/kg and 5.0mg/kg groups, respectively, while no severe side effects were seen in either the IMF or control groups, except for mild anolexia and ref lexible vomiting. Ulcers and erosions with hemorrhage were seen in the pyloroduodenum and severe ulcers were observed in the IND 1.7mg/kg and 5.0mg/kg. These abnormalities were also confirmed in the histological examination. Similar reductions of PGE2⋅I2 when compared with the control group were detected in the pyloroduodenum in both the IMF and IND groups but there was a significant difference in mucosal damage between them. It is therefore most likely that the inhibition of PGs syntheses by IND is not solely responsible for the mucosal damage and some other factors may be involved. In terms of anti-inflammatory effect, although IMF at 30mg/kg was weaker than IND at 5.0mg/kg, IMF had a similar effect or was a little stronger than IND at 1.7mg/kg. Even at the same effective dose, the frequency of side effects for IMF was much less for IND. These results indicate that IMF, a prodrug of IND, has a different action from IND, and is prefered since IMF would expect to cause lesser side effects associated with IND.


Japanese Journal of Pharmacology | 1994

Effects of Menatetrenone on the Decrease in Calcium Balance Induced by Vitamin K-Deficient Diet and Sodium Loading in Rats

Takashi Tomiuga; Masatoshi Kobayashi; Yoshikage Nakajima; Motoaki Bessho; Yoshinori Katoh; Kuniko Hara; Yasuhiro Akiyama; Tetsuya Nakamura; Tetsuya Tajima


Folia Pharmacologica Japonica | 1988

Study on producing rats with experimental testicular dysfunction and effects of mecobalamin

Satoru Ozaki; Isao Ohkawa; Yoshinori Katoh; Tetsuya Tajima; Masaichi Kimura; Seiichi Orikasa


Archive | 1983

A pharmaceutical composition and the use thereof for the treatment of inflammation

Yoshinori Katoh; Tetsuya Tajima; Isao Yamatsu; Takeshi Suzuki; Shinya Abe; Akiharu Kajihara; Tohru Sugitani


Folia Pharmacologica Japonica | 1998

[Protective effects of teprenone and gefarnate against taurocholate/hydrochloric acid-induced acute gastric mucosal lesions in rats].

Yoshinori Katoh; Mamoru Tanaka; Hidetoshi Kawashima


Archive | 1986

Polyprenyl compounds, process for the production thereof and medicines containing same

Isao Yamatsu; Shinya Abe; Yuichi Inai; Takeshi Suzuki; Kensaku Kinoshita; Mannen Mishima; Yoshinori Katoh; Seiichi Kobayashi; Manabu Murakami; Kouzi Yamada


Archive | 1984

Polyprenyl esters of acemethacins and anti-inflammatory method of use thereof

Isao Yamatsu; Shinya Abe; Yuichi Inai; Takeshi Suzuki; Kensaku Kinoshita; Mannen Mishima; Yoshinori Katoh; Seiichi Kobayashi; Manabu Murakami; Kouzi Yamada


Folia Pharmacologica Japonica | 1997

A new model of delayed healing of acetic acid ulcers in rats by indomethacin via osmotic pump

Mamoru Tanaka; Yoshinori Katoh; Hidetoshi Kawashima


Archive | 1982

COMPOSTI DI POLIPRENILE,PROCESSO PER LA PRODUZIONE DEGLI STESSI E MEDICINE CONTENENTI I MEDESIMI

Isao Yamatsu; Shinya Abe; Yuichi Inai; Takeshi Suzuki; Kensaku Kinoshita; Mannen Mishima; Yoshinori Katoh; Seiichi Kobayashi; Manabu Murakami; Kouzi Yamada


Archive | 1982

Polyprenylverbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten Polyprenyl compounds, processes for their preparation and pharmaceutical compositions containing these

Isao Yamatsu; Shinya Abe; Yuichi Inai; Takeshi Suzuki; Kensaku Kinoshita; Mannen Mishima; Yoshinori Katoh; Seiichi Kobayashi; Manabu Murakami; Kouzi Yamada

Collaboration


Dive into the Yoshinori Katoh's collaboration.

Researchain Logo
Decentralizing Knowledge